Susquehanna International Group
THRX

Susquehanna International Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Susquehanna International Group’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,112
Closed -$33.9K – 13578
2023
Q3 		$29.9K Buy
+11,112
New +$43.6K ﹤0.01% 11486
2022
Q3 		– Sell
-22,402
Closed -$124K – 14400
2022
Q2 		$124K Buy
+22,402
New +$185K ﹤0.01% 11249

Susquehanna International Group's THRX Position: Q4 2023 in Review

Susquehanna International Group sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q4 2023, closing a stake of 11,112 shares — an estimated $33.9K sold.

Susquehanna International Group first reported a position in THRX in Q2 2022 and held it in 2 quarters. The position peaked at $124K in Q2 2022. 70 funds tracked by Wall St. Rank hold THRX as of Q4 2023.

  • Susquehanna International Group reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 11,112 Theseus Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $33.9K.
  • Susquehanna International Group first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Susquehanna International Group's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $124K in Q2 2022.
  • 70 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.